(Q40556092)
Statements
1 reference
Safety of palivizumab in preterm infants 29 to 32 weeks' gestational age without chronic lung disease to prevent serious respiratory syncytial virus infection (English)
1 reference
Groothuis JR
1 reference
24 June 2003
1 reference
1 reference
22
1 reference
7
1 reference
414-417
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference